Whole‐blood dysregulation of actin‐cytoskeleton pathway in adult spinal muscular atrophy patients

Recent advances in therapeutics have improved prognosis for severely affected spinal muscular atrophy (SMA) type 1 and 2 patients, while the best method of treatment for SMA type 3 patients with later onset of disease is unknown. To better characterize the SMA type 3 population and provide potential therapeutic targets, we aimed to understand gene expression differences in whole blood of SMA type 3 patients (n = 31) and age‐ and gender‐matched controls (n = 34).

[1]  K. Swoboda,et al.  Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy , 2019, Neurology.

[2]  R. Finkel,et al.  Neurofilament as a potential biomarker for spinal muscular atrophy , 2019, Annals of clinical and translational neurology.

[3]  I. Oda,et al.  RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach , 2018, Modern Pathology.

[4]  Ewout J. N. Groen,et al.  Advances in therapy for spinal muscular atrophy: promises and challenges , 2018, Nature Reviews Neurology.

[5]  P. Claus,et al.  The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration? , 2018, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[6]  R. J. Ramamurthi,et al.  Nusinersen versus Sham Control in Infantile‐Onset Spinal Muscular Atrophy , 2017, The New England journal of medicine.

[7]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[8]  R. Finkel,et al.  Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study , 2016, The Lancet.

[9]  G. Comi,et al.  Spinal muscular atrophy—recent therapeutic advances for an old challenge , 2015, Nature Reviews Neurology.

[10]  J. Cools.  RHOA mutations in peripheral T cell lymphoma , 2014, Nature Genetics.

[11]  K. High,et al.  Immune responses to AAV vectors: overcoming barriers to successful gene therapy. , 2013, Blood.

[12]  R. Finkel,et al.  Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study , 2012, PloS one.

[13]  R. Finkel,et al.  Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study , 2012, PloS one.

[14]  B. Wirth,et al.  The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. , 2011, Human molecular genetics.

[15]  M. Schroth,et al.  SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy , 2011, PloS one.

[16]  M. Schroth,et al.  Compound muscle action potential and motor function in children with spinal muscular atrophy , 2010, Muscle & nerve.

[17]  R. Dominguez,et al.  Regulation of actin cytoskeleton dynamics in cells , 2010, Molecules and cells.

[18]  Y. Hua,et al.  A positive modifier of spinal muscular atrophy in the SMN2 gene. , 2009, American journal of human genetics.

[19]  H. Yin,et al.  RhoA required for acid-induced stress fiber formation and trafficking and activation of NHE3. , 2007, American journal of physiology. Renal physiology.

[20]  M. Schroth,et al.  Perspectives on Clinical Trials in Spinal Muscular Atrophy , 2007, Journal of child neurology.

[21]  M. Bowerman,et al.  Smn Depletion Alters Profilin II Expression and Leads to Upregulation of the RhoA/ROCK Pathway and Defects in Neuronal Integrity , 2007, Journal of Molecular Neuroscience.

[22]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Christophe Ampe,et al.  A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells. , 2005, Experimental cell research.

[24]  Mark B Bromberg,et al.  Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function , 2005, Annals of neurology.

[25]  M. Bromberg,et al.  Motor unit number estimation in infants and children with spinal muscular atrophy , 2002, Muscle & nerve.

[26]  T. Svitkina.  The Actin Cytoskeleton and Actin-Based Motility. , 2018, Cold Spring Harbor perspectives in biology.

[27]  Xueer Wang,et al.  RhoA regulates Activin B-induced stress fiber formation and migration of bone marrow-derived mesenchymal stromal cell through distinct signaling. , 2017, Biochimica et biophysica acta. General subjects.

[28]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..